A turning point in therapy for ameloblastomas

Ameloblastoma is a benign but locally aggressive odontogenic neoplasm in the jaw and maxilla [1,2]. If untreated, these lesions can reach enormous sizes and sometimes pose an airway risk. Although most are nonmetastasizing, they frequently recur if not adequately resected [3]. The current standard therapy for ameloblastoma is complete bone resection (radical intervention) with an adequate margin of safety, which is classified as marginal or segmental osteotomy for the mandible, and partial or total maxillectomy for the maxilla [1,4].

http://ift.tt/2p6ijak